Assessment of knowledge and attitude of adverse drug reactions among healthcare professionals in Bangladesh
Sanjoy Kumer Paul
Abstract
Adverse drug reactions have increased significantly in people as many new drugs have come to the market in the last two decades. This has not only economic consequences but also causes morbidity and mortality. In Bangladesh, some incidents happened related to drug problems and it took several lives. Spontaneous reporting of adverse drug reactions can primarily control this situation and healthcare professionals can play an immeasurable role. Therefore, this study was aimed to be conducted at seven different hospitals and diagnostic centers to find out the actual scenario of adverse drug reactions among the healthcare professionals in Bangladesh to make them aware of adverse drug reactions and the reporting system, and to know about their opinion towards adverse drug reactions. However, after evaluation of the questionnaires it was found that a large number of healthcare professionals were not aware of adverse drug reactions and pharmacovigilance, especially the nurses. It was found that 13.3% of nurses did not know about adverse drug reactions and 93.3% of them had not reported any reactions. Furthermore, many healthcare professionals did not show a positive attitude towards pharmacovigilance. If proper pharmacovigilance practice cannot be started, the nation will face serious economic and health-related problems.
Keywords
References
- Nahar N, Khan MTH, Banu LA, Khan MI, Hossain AM (2017) Perceptions of medical practitioner regarding adverse drug reactions reporting and pharmacovigilance. Journal of Shaheed Suhrawardy Medical College. 6 (1): 18-22. doi: 10.3329/jssmc.v6i1.314
- Patton K, Borshoff DC (2018) Adverse drug reactions. Anaesthesia. 73: 76-84. doi: 10.1111/anae.14143
- Ajayi FO, Sun H, Perry J (2000) Adverse drug reactions: A review of relevant factors. Journal of Clinical Pharmacology. 40 (10): 1093-1093101. doi: 10.1177/009127000004001003
- Shamna M, Dilip C, Ajmal M, Linu Mohan P, Shinu C, Jafer CP, Mohammed Y (2014) A prospective study on adverse drug reactions of antibiotics in a tertiary care hospital. Saudi Pharmaceutical Journal. 22 (4): 303-308. doi: 10.1016/j.jsps.2013.06.004
- Sherif FM (2017) Role of the pharmacist in adverse drug reaction monitoring. Pharmacy and Pharmacology International Journal. 5 (5): 00133. doi: 10.15406/ppij.2017.05.00133
- AlShammari TM, Almoslem MJ (2018) Knowledge, attitudes and practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: A multi-center cross sectional study. Saudi Pharmaceutical Journal. 26 (7): 925-931. doi: 10.1016/j.jsps.2018.04.012
- Iasella CJ, Johnson HJ, Dunn MA (2017) Adverse drug reactions: Type A (Intrinsic) or Type B (Idiosyncratic). Clinics in liver disease. 21 (1): 73-87. doi: 10.1016/j.cld.2016.08.005
- Kaufman G (2016) Adverse drug reactions: classification, susceptibility and reporting. Nursing Standard (Royal College of Nursing (Great Britain). 30 (50): 53-63. doi: 10.7748/ns.2016.e10214
- Phillips EJ (2016) Classifying ADRs - Does dose matter? British Journal of Clinical Pharmacology. 81 (1): 10-12. doi: 10.1111/bcp.12749
- Martin LG, Hanssens Y, Paudyal V (2018) Overview of this issue: Pharmacovigilance, what is new? International Journal of Clinical Pharmacy. 40 (4): 737-739. doi: 10.1007/s11096-018-0719-4
- Talbot JCC, Nilsson BS (1998) Pharmacovigilance in the pharmaceutical industry. British Journal of Clinical Pharmacology. 45 (5): 427-431. doi: 10.1046/j.1365-2125.1998.00713.x
- Inácio P, Cavaco A, Airaksinen M (2017) The value of patient reporting to the pharmacovigilance system: A systematic review. British Journal of Clinical Pharmacology. 83 (2): 227-246. doi: 10.1111/bcp.13098
- Varallo FR, Planeta CS, Mastroianni P deC (2017) Effectiveness of pharmacovigilance: Multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff. Clinics. 72 (1): 51-57. doi: 10.6061/clinics/2017(01)09
- Giezen TJ, Mantel-Teeuwisse AK, Leufkens HGM (2009) Pharmacovigilance of biopharmaceuticals: Challenges remain. Drug Safety. 32 (10): 811-817. doi: 10.2165/11316550-000000000-00000
- Jahan N, Hossain MA, Hossain MA, Amran MS (2017) Review on pharmacovigilance practice for safety of medication system in Bangladesh. Bangladesh Pharmaceutical Journal. 20 (1): 105-114. doi: 10.3329/bpj. v20i1.32100
- Van Eekeren R, Rolfes L, Koster AS, Magro L, Parthasarathi G, Al Ramimmy H, Schutte T, Tanaka D, van Puijenbroek E, Härmark L (2018) What future healthcare professionals need to know about pharmacovigilance: Introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects. Drug Safety. 41 (11): 1003-1011. doi: 10.1007/ s40264-018-0681-z
- Sportiello L, Rafaniello C, Scavone C, Vitale C, Rossi F, Capuano A (2016) The importance of pharmaco-vigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy. International Journal of Cardiology. 202: 731-735. doi: 10.1016/j.ijcard.2015.10.002
- Helali AM, Iqbal MJ, Islam MZ, Haque M (2014) The evolving role of pharmacovigilance and drug safety: The way forward for Bangladesh. International Journal of Pharmaceutical Research. 6 (4): 31-37. doi: Nil.
- Welfare F (2023) National guidelines on the pharmacovigilance system in Bangladesh. Ministry of Health and Family Welfare Government of the People’s Republic of Bangladesh.
- Almustansir M, Saha D, Paul S, Rahim Z Bin, Hosen SMZ (2013) Studies on pharmacovigilance in Bangladesh: Safety issues. International Journal of Pharmacy Teaching & Practices. 14 (2): 613-621. doi: Nil.
- Hossain AM (2016) Need of pharmacovigilance education and awareness in Bangladesh. The Pharma World. Pharmaceutical and Health Journal of Bangladesh. 2016 (7); 1-3. doi: Nil.
- Hossain AM, Amran SM (2019) A cross-sectional pilot study on pharmacovigilance to improve the drug safety in Bangladesh. Biomedical and Pharmacology Journal. 12 (3): 1039-1049. doi: 10.13005/bpj/1733
- Chowdhury MNG, Hoque ME, Khan, MAL, Khan MSI (2016) Severe cutaneous adverse drug reactions in Bangladesh: A review in a Tertiary Level Hospital. Journal of Armed Forces Medical College, Bangladesh. 12 (2): 71-75. doi: 10.3329/jafmc.v12i2.41098
- Nahar N, Karim A, Paul PC, Khan TK (2011) Response of reporting adverse drug reactions among medical practitioners. Bangladesh Medical Journal. 40 (2): 13-18. doi: 10.3329/bmj.v40i2.18498
- Begum ZA, Sultana S, Umar BU, Thoo-Lin PK, Uddin MK, Islam SMH (2012) Study of adverse drug reactions in out-patient departments of a teaching hospital. Bangladesh Journal of Pharmacology. 7 (2): 104-107. doi: 10.3329/bjp.v7i2.10760
- Elfituri AA, Sherif FM (2022) Novel clinical pharmacy practice: extended role and improved competencies. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2 (1): 1-3. doi: 10.5281/zenodo.6397651
- Elyamani MA, Sherif FM (2021) Assessment of drug prescribing pattern and prescription errors in elderly patients. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 1 (2): 46-50. doi: 10.5281/zenodo. 6780506
Submitted date:
04/03/2025
Reviewed date:
04/19/2025
Accepted date:
04/23/2025
Publication date:
04/24/2025